Abstract
So far, the only specific chromosome abnormality in haematological disorders is the Ph1-chromosome. Chromosome abnormalities have been described in so-called idiopathic side-roblastic or refractory anaemias1 but a constant cytogenetic abnormality associated with a defined clinical syndrome has not been reported.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
De Grouchy, J., Denava, C., Zittoun, R., and Bousser, J., Nouv. Rev. Fr. Hemat., 3, 367–388 (1966).
Dreyfus, B., Rochant, H., Sultan, C., Clauvel, J. P., Yvari, J., and Chesneau, A. M., Presse méd., 78, 359–364 (1970).
Fitzgerald, P. H., and Hamer, J. W., Blood, 38, 325–335 (1971).
Price, P. M., Conover, J. H., and Hirschhorn, K., Nature, 237, 340–342 (1972).
Author information
Authors and Affiliations
Additional information
Address for reprints, Minderbroedersstraat; 12, B-3000 Leuven, Belgium.
Rights and permissions
About this article
Cite this article
VAN DEN BERGHE, H., CASSIMAN, JJ., DAVID, G. et al. Distinct haematological disorder with deletion of long arm of No. 5 chromosome. Nature 251, 437–438 (1974). https://doi.org/10.1038/251437a0
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1038/251437a0
This article is cited by
-
The functional mechanisms of mutations in myelodysplastic syndrome
Leukemia (2019)
-
A decade of progress in myelodysplastic syndrome with chromosome 5q deletion
Leukemia (2018)
-
Current and Future Treatment Options for Myelodysplastic Syndromes: More Than Hypomethylating Agents and Lenalidomide?
Drugs (2018)
-
The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia
Nature Reviews Cancer (2017)
-
Long-Term Maintenance of Hematological and Cytogenetic Remission in 5q- Syndrome After Short-Term Administration of Lenalidomide
Indian Journal of Hematology and Blood Transfusion (2017)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
